A Multi-center, Randomized, Double-Blind, Placebo-Controlled, Single Dose, Efficacy and Safety Outpatient Study of StaccatoTM Prochlorperazine for Inhalation in Patients With Migraine Headache
Phase of Trial: Phase II
Latest Information Update: 29 Jan 2018
At a glance
- Drugs Prochlorperazine (Primary)
- Indications Migraine
- Focus Therapeutic Use
- Sponsors Alexza Pharmaceuticals
- 07 Jun 2007 Results were reported at AHS 2007.
- 07 Jun 2007 Status change from in progress to completed.
- 27 Mar 2007 Interim results have been reported.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History